132
Views
2
CrossRef citations to date
0
Altmetric
Letter to the Editor

QT interval corrected for heart rate is not associated with mortality in patients with cirrhosis and ascites

, , , , &
Pages 1376-1378 | Received 01 Oct 2019, Accepted 02 Oct 2019, Published online: 14 Oct 2019
 

Acknowledgements

The authors thank Sanofi-Aventis R&D for providing access to the complete trial database from the satavaptan phase III trials in cirrhotic ascites and for permission to perform the analyses included in this publication.

Disclosure statement

No potential conflict of interest was reported by the authors.

Additional information

Funding

Henrik Kjaerulf Jensen is supported by the Novo Nordisk Foundation, Denmark [NNF18OC0031258].

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.